A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
- PMID: 8259215
- DOI: 10.1038/366704a0
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
Abstract
The division cycle of eukaryotic cells is regulated by a family of protein kinases known as the cyclin-dependent kinases (CDKs). The sequential activation of individual members of this family and their consequent phosphorylation of critical substrates promotes orderly progression through the cell cycle. The complexes formed by CDK4 and the D-type cyclins have been strongly implicated in the control of cell proliferation during the G1 phase. CDK4 exists, in part, as a multi-protein complex with a D-type cyclin, proliferating cell nuclear antigen and a protein, p21 (refs 7-9). CDK4 associates separately with a protein of M(r) 16K, particularly in cells lacking a functional retinoblastoma protein. Here we report the isolation of a human p16 complementary DNA and demonstrate that p16 binds to CDK4 and inhibits the catalytic activity of the CDK4/cyclin D enzymes. p16 seems to act in a regulatory feedback circuit with CDK4, D-type cyclins and retinoblastoma protein.
Comment in
-
Cell cycle. Dams and sluices.Nature. 1993 Dec 16;366(6456):634-5. doi: 10.1038/366634a0. Nature. 1993. PMID: 8259207 No abstract available.
Similar articles
-
Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.Cell Growth Differ. 1998 Aug;9(8):595-610. Cell Growth Differ. 1998. PMID: 9716177
-
Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.Mol Carcinog. 1998 Jun;22(2):128-43. Mol Carcinog. 1998. PMID: 9655257
-
The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.Cancer Res. 1996 Dec 1;56(23):5475-83. Cancer Res. 1996. PMID: 8968104
-
[Cyclin D, CDK4 and p16 expression in colorectal cancer].Nihon Rinsho. 1996 Apr;54(4):1054-9. Nihon Rinsho. 1996. PMID: 8920673 Review. Japanese.
-
The D-type cyclins and their role in tumorigenesis.J Cell Sci Suppl. 1994;18:89-96. doi: 10.1242/jcs.1994.supplement_18.13. J Cell Sci Suppl. 1994. PMID: 7883799 Review.
Cited by
-
Gene therapy for advanced melanoma: selective targeting and therapeutic nucleic acids.J Drug Deliv. 2013;2013:897348. doi: 10.1155/2013/897348. Epub 2013 Mar 25. J Drug Deliv. 2013. PMID: 23634303 Free PMC article.
-
Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics.Int J Mol Sci. 2021 Mar 29;22(7):3553. doi: 10.3390/ijms22073553. Int J Mol Sci. 2021. PMID: 33805567 Free PMC article. Review.
-
Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.BMC Cancer. 2015 May 9;15:379. doi: 10.1186/s12885-015-1397-4. BMC Cancer. 2015. PMID: 25956431 Free PMC article.
-
mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas.Clin Cancer Res. 2012 May 1;18(9):2558-68. doi: 10.1158/1078-0432.CCR-11-2824. Epub 2012 Mar 12. Clin Cancer Res. 2012. PMID: 22409888 Free PMC article.
-
p16High immune cell - controlled disease tolerance as a broad defense and healthspan extending strategy.bioRxiv [Preprint]. 2024 Jul 15:2024.07.15.603540. doi: 10.1101/2024.07.15.603540. bioRxiv. 2024. PMID: 39026790 Free PMC article. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases